Revive Therapeutics Ltd C.RVV

RVV Clinical-Trial phase 3 >>> Important dates >>>

[TheTerminator1]

Study Type  :	Interventional  (Clinical Trial)
Estimated Enrollment  :	1000 participants
Allocation:	Randomized
Intervention Model:	Parallel Assignment
Masking:	Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description:	Double-blind, placebo controlled
Primary Purpose:	Treatment
Official Title:	Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of Bucillamine in Patients With Mild-Moderate COVID-19
Actual Study Start Date  :	November 27, 2020
Estimated Primary Completion Date  :	July 25, 2021
Estimated Study Completion Date  :	August 25, 2021

[1ottrunner]

Let's hope they don;t move this target like they have in the past.   Record Verification: August 2020 July 2021 Overall Status: Not yet recruiting Enrolling by invitation Study Start: August 30, 2020 November 27, 2020 Primary Completion: September 1 July 25, 2021 [Anticipated]